Clinical Trial Update: HER-2 B Cell Peptide Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a HER-2 B cell peptide vaccine in metastatic breast and gastric cancers; recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Gastrointestinal Cancer

Drugs mentioned

• HER-2 B cell peptide vaccine

Snippet

Sponsor: Pravin T.P Kaumaya | Conditions: Metastatic Breast Cancer, Metastatic Gastrointestinal Carcinoma | Phase 1 | Status: RECRUITING